Stoke Therapeutics
STOK
STOK
107 hedge funds and large institutions have $369M invested in Stoke Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.07% less ownership
Funds ownership: 107.24% → 102.17% (-5.1%)
31% less capital invested
Capital invested by funds: $533M → $369M (-$164M)
Holders
107
Holding in Top 10
2
Calls
$183K
Puts
$41K
Top Buyers
| 1 | +$6.83M | |
| 2 | +$2.69M | |
| 3 | +$2.02M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.85M |
| 5 |
BlackRock
New York
|
+$1.14M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$6.01M | |
| 3 | -$4.33M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.12M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.16M |